Department of Surgery, Johns Hopkins University School of Medicine, Baltimore, MD.
Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD.
Transplantation. 2024 Feb 1;108(2):530-538. doi: 10.1097/TP.0000000000004779. Epub 2023 Aug 29.
Kidney transplant (KT) recipients have numerous risk factors for delirium, including those shared with the general surgical population (eg, age and major surgery) and transplant-specific factors (eg, neurotoxic immunosuppression medications). Evidence has linked delirium to long-term dementia risk in older adults undergoing major surgery. We sought to characterize dementia risk associated with post-KT delirium.
Using the United States Renal Data System datasets, we identified 35 800 adult first-time KT recipients ≥55 y. We evaluated risk factors for delirium using logistic regression. We evaluated the association between delirium and incident dementia (overall and by subtype: Alzheimer's, vascular, and other/mixed-type), graft loss, and death using Fine and Gray's subhazards models and Cox regression.
During the KT hospitalization, 0.9% of recipients were diagnosed with delirium. Delirium risk factors included age (OR = 1.40, 95% CI, 1.28-1.52) and diabetes (OR = 1.38, 95% CI, 1.10-1.73). Delirium was associated with higher risk of death-censored graft loss (aHR = 1.52, 95% CI, 1.12-2.05) and all-cause mortality (aHR = 1.53, 95% CI, 1.25-1.89) at 5 y post-KT. Delirium was also associated with higher risk of dementia (adjusted subhazard ratio [aSHR] = 4.59, 95% CI, 3.48-6.06), particularly vascular dementia (aSHR = 2.51, 95% CI, 1.01-6.25) and other/mixed-type dementia (aSHR = 5.58, 95% CI, 4.24-7.62) subtypes. The risk of all-type dementia associated with delirium was higher for younger recipients aged between 55 and 64 y ( Pinteraction = 0.01).
Delirium is a strong risk factor for subsequent diagnosis of dementia among KT recipients, particularly those aged between 55 and 64 y at the time of transplant. Patients experiencing posttransplant delirium might benefit from early interventions to enhance cognitive health and surveillance for cognitive impairment to enable early referral for dementia care.
肾移植 (KT) 受者存在多种发生谵妄的风险因素,包括与普通外科人群共有的风险因素(如年龄和大手术)和移植特异性因素(如神经毒性免疫抑制药物)。有证据表明,谵妄与接受大手术的老年患者长期痴呆风险相关。我们旨在描述与 KT 后谵妄相关的痴呆风险。
我们使用美国肾脏数据系统数据集,确定了 35800 名年龄≥55 岁的首次接受 KT 的成年患者。我们使用逻辑回归评估谵妄的风险因素。我们使用 Fine 和 Gray 的亚风险模型和 Cox 回归评估谵妄与新发痴呆(总体和亚型:阿尔茨海默病、血管性和其他/混合性)、移植物丢失和死亡之间的关联。
在 KT 住院期间,有 0.9%的受者被诊断为谵妄。谵妄的风险因素包括年龄(OR=1.40,95%CI,1.28-1.52)和糖尿病(OR=1.38,95%CI,1.10-1.73)。谵妄与 5 年时死亡相关的移植物丢失风险增加(aHR=1.52,95%CI,1.12-2.05)和全因死亡率(aHR=1.53,95%CI,1.25-1.89)相关。谵妄也与痴呆风险增加相关(调整后的亚危险比[aSHR]=4.59,95%CI,3.48-6.06),尤其是血管性痴呆(aSHR=2.51,95%CI,1.01-6.25)和其他/混合性痴呆(aSHR=5.58,95%CI,4.24-7.62)亚型。与谵妄相关的所有类型痴呆的风险在年龄在 55 至 64 岁之间的年轻受者中更高(P 交互=0.01)。
谵妄是 KT 受者随后发生痴呆的一个强有力的危险因素,尤其是在移植时年龄在 55 至 64 岁之间的受者。接受移植后出现谵妄的患者可能受益于早期干预措施,以增强认知健康,并对认知障碍进行监测,以便早期转介进行痴呆护理。